Search results for: 'Platform Science'

New technological advances in life science instrumentation and research tools include the enhancement of next-generation sequencing (NGS) technology, digital PCR, and a wide range of informatics, robotics, and automated solutions. These improve workflow, facilitate and automate tasks, and make better use of workspaces in every area of industry. ...

An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...

This project provides an overview of the effects of generative AI (Gen AI) on the healthcare and life science industry and numerous growth opportunities, including how it could overcome regulatory and cybersecurity obstacles, address the build-borrow-buy conundrum, and impact the value chain of pharmaceutical companies, medical device developers, p...

The year 2023 will begin with three disruptive forces already playing out. The first is inflationary pressure on wages. The global labor market is expected to remain tight due to aging workforces and stringent immigration policies. The COVID-19 pandemic’s impact on labor force turnover rates will keep price inflation higher than pre-pandemic lev...

28 Aug 2020  |  Global  |  Technology Research

Data Science Impacting the Pharmaceutical Industry

Part I: Drug Discovery Applications

Infographics

×

Data science and AI have the potential to transform drug discovery in terms of costs, speed and efficiency. With explosion in biomedical data, data sharing and analysis platforms have surged. AI technologies are moving to the next phase of advancements, and when combined with other emerging tech areas, AI is expected to witness a full fledged adopt...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

Globally, businesses are reestablishing themselves in geopolitically unstable markets, with an emphasis on unlocking data's potential and leveraging artificial intelligence (AI) to support business outcomes. About 87% of enterprises believe AI and machine learning (ML) are important in achieving business goals to grow revenue, increase operational ...

In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transpire ...